Psychiatry

814 soru

Soru 561Soru →

A 28-year-old woman is brought to the outpatient clinic by her husband for evaluation of abnormal behavior and low mood. For the past 10 weeks, she has exhibited profound sadness, extreme fatigue, and hypersomnia, often sleeping 14 hours a day. Her husband reports that for the last 6 weeks, she has been responding to unseen stimuli and admits to hearing a persistent voice calling her a "worthless failure."

Two years ago, the patient experienced a 2-week episode of euphoric mood, boundless energy, and rapid speech. During that time, she slept only 2 hours a night and spent the couple's entire savings on unneeded luxury goods, which required a brief psychiatric hospitalization.

She currently takes no medications but asks if she can be started on a combination of a selective serotonin reuptake inhibitor (SSRI) and a monoamine oxidase inhibitor (MAOI), as she read online that this combination is highly effective for severe depression.

Laboratory evaluation shows:
Thyroid-stimulating hormone (TSH): 1.8 µU/mL (Normal: 0.5-5.0 µU/mL)
Free thyroxine (T4): 0.5 ng/dL (Normal: 0.9-1.7 ng/dL)

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Initiate quetiapine monotherapy

Cevap

Initiate quetiapine monotherapy
The correct action is to initiate quetiapine monotherapy. This patient has Bipolar I disorder, as evidenced by her past manic episode (euphoria, decreased sleep, impulsivity requiring hospitalization). She is currently experiencing a major depressive episode with psychotic features (sadness, hypersomnia, and auditory hallucinations). Quetiapine is a second-generation (atypical) antipsychotic with proven efficacy as monotherapy for bipolar depression. It is particularly appropriate in this case as it simultaneously treats the depressive mood symptoms and the psychotic symptoms without the risk of inducing a manic switch.

Adım Adım Çözüm

1
Identify the current clinical syndrome.
The patient has a 10-week history of severe depression with 6 weeks of auditory hallucinations, indicating a major depressive episode with psychotic features.
Accurate characterization of the current episode is required to guide treatment.
2
Review the patient's past psychiatric history.
The patient had a distinct 2-week episode of euphoria, decreased need for sleep, and impulsivity requiring hospitalization, which meets the criteria for a manic episode.
A history of mania changes the diagnosis from Major Depressive Disorder to Bipolar I Disorder.
3
Select the appropriate pharmacotherapy.
Quetiapine monotherapy is selected.
Atypical antipsychotics such as quetiapine are first-line treatments for bipolar depression with psychotic features, as they avoid the risk of antidepressant-induced manic switching.

Anahtar Kavram

Patients presenting with depressive episodes must be screened for a history of mania to differentiate unipolar depression from bipolar disorder; bipolar depression is treated with mood stabilizers or specific atypical antipsychotics to avoid inducing a manic episode.
Soru 562Soru →

A 17-year-old girl is admitted to the hospital for medical stabilization of severe anorexia nervosa, restricting subtype. Her body mass index on admission is 12.5 kg/m212.5 \text{ kg/m}^2. Her home medication of fluoxetine is continued. Routine admission laboratories reveal a normal thyroid-stimulating hormone (TSH) level with a low total T3 and low-normal free T4. Due to her profound malnutrition, continuous nasogastric tube feeding is initiated at a high caloric rate to promote rapid weight gain. On the third day of hospitalization, the patient suddenly develops significant shortness of breath, a cough productive of pink frothy sputum, and orthopnea. Her temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), pulse is 118/min118\text{/min}, respirations are 28/min28\text{/min}, and blood pressure is 92/60 mmHg92/60\text{ mmHg}. Physical examination reveals distinct jugular venous distention and bilateral basilar lung crackles. Which of the following is the most likely primary mechanism for this patient's acute clinical deterioration?

Cevabı ve açıklamayı göster

Cevap: Intracellular shift of phosphate resulting in myocardial adenosine triphosphate depletion

Cevap

The correct mechanism is an intracellular shift of phosphate resulting in myocardial adenosine triphosphate (ATP) depletion.
This patient is experiencing refeeding syndrome, a classic and highly lethal complication of rapid nutritional rehabilitation in profoundly malnourished individuals (such as those with severe anorexia nervosa). Introducing a high-carbohydrate load triggers a massive surge in insulin secretion. Insulin drives the cellular uptake of glucose along with phosphate, potassium, and magnesium. Because these patients already have severely depleted total body stores of these minerals (even if initial serum levels appear normal), this sudden intracellular shift causes profound hypophosphatemia, hypokalemia, and hypomagnesemia. Phosphate is fundamentally essential for the production of adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (2,3-DPG). The rapid depletion of ATP results in generalized cellular dysfunction, notably myocardial contractility failure (acute congestive heart failure), while low 2,3-DPG impairs oxygen release to tissues. The patient's acute jugular venous distention, orthopnea, pink frothy sputum, and crackles are direct signs of this cardiogenic pulmonary edema.

Adım Adım Çözüm

1
Analyze the patient's acute symptoms and physical examination findings.
The combination of significant shortness of breath, orthopnea, pink frothy sputum, tachycardia, hypotension, jugular venous distention, and basilar crackles indicates acute decompensated heart failure and pulmonary edema.
Accurately identifying the clinical syndrome (cardiogenic failure vs. primary pulmonary disease) is the essential first step in determining the underlying mechanism.
2
Correlate the acute heart failure with the patient's specific clinical context.
The patient is profoundly malnourished (BMI 12.5) and recently started on a high-calorie enteral feeding regimen. This specific timeline and trigger point strongly to refeeding syndrome.
Medical stabilization of severe eating disorders requires careful management to prevent complications of nutritional rehabilitation.
3
Determine the biochemical mechanism of refeeding syndrome that leads to heart failure.
A high carbohydrate load triggers a massive insulin surge, which drives phosphate, magnesium, and potassium into cells. The resulting severe hypophosphatemia leads to depleted ATP and 2,3-DPG, causing myocardial tissue hypoxia and contractility failure.
Understanding the precise electrolyte shift distinguishes refeeding syndrome from other causes of deterioration like endocrine abnormalities or drug interactions.

Anahtar Kavram

Refeeding syndrome is a life-threatening complication of rapid nutritional rehabilitation in severe anorexia nervosa, characterized by insulin-driven intracellular shifts of phosphate, potassium, and magnesium, leading to ATP depletion and subsequent cardiopulmonary failure.
Soru 563Soru →

Correlate the following clinical scenarios involving psychotropic polypharmacy with their underlying pharmacokinetic or pharmacodynamic interaction mechanisms and resulting clinical consequences.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Initiation of valproate in a patient currently stabilized on lamotrigine without preemptive dose adjustment.
Addition of fluvoxamine for obsessive-compulsive symptoms in a patient stabilized on clozapine.
Concurrent administration of carbamazepine and clozapine for refractory schizoaffective disorder.
Prescribing paroxetine for comorbid anxiety in a patient maintained on a stable dose of haloperidol.
Patient initiation of over-the-counter St. John's Wort while maintained on quetiapine.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The clinical polypharmacy scenarios correctly map to their specific pharmacokinetic (e.g., CYP450 or UGT inhibition/induction) or pharmacodynamic mechanisms, leading to characteristic adverse outcomes.
Each psychotropic medication combination produces a highly specific and predictable pharmacokinetic or pharmacodynamic interaction. Mastering these pathways (CYP1A2, CYP2D6, CYP3A4, UGT) is essential for avoiding catastrophic iatrogenic outcomes like Stevens-Johnson syndrome, agranulocytosis, or fatal toxicities.

Adım Adım Çözüm

1
Analyze the lamotrigine and valproate interaction.
Matches with UGT inhibition leading to Stevens-Johnson syndrome.
Valproate inhibits glucuronidation (UGT), which is the sole clearance mechanism for lamotrigine.
2
Analyze the clozapine and fluvoxamine interaction.
Matches with CYP1A2 inhibition leading to seizures.
Fluvoxamine specifically targets CYP1A2, sharply elevating clozapine to toxic, epileptogenic levels.
3
Analyze the clozapine and carbamazepine interaction.
Matches with synergistic neutropenia and CYP3A4 induction.
Both drugs cause agranulocytosis. Pharmacokinetically, carbamazepine accelerates clozapine clearance.
4
Analyze the haloperidol and paroxetine interaction.
Matches with CYP2D6 inhibition leading to extrapyramidal symptoms.
Paroxetine blocks CYP2D6, slowing haloperidol metabolism and causing dose-dependent motor side effects.
5
Analyze the quetiapine and St. John's Wort interaction.
Matches with CYP3A4 induction leading to clinical destabilization.
St. John's Wort induces the CYP3A4 enzyme, stripping quetiapine from the blood and causing subtherapeutic levels.

Anahtar Kavram

Pharmacokinetic (CYP450 and UGT) and pharmacodynamic drug-drug interactions in psychopharmacology.
Soru 564Soru →

Match each patient presentation with the mechanism of action of the most appropriate pharmacotherapy for their clinical scenario.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 45-year-old man with severe alcohol use disorder and decompensated cirrhosis (ascites, jaundice) seeking medication to maintain abstinence.
A 52-year-old woman with severe alcohol use disorder and end-stage renal disease on hemodialysis seeking medication to reduce cravings.
A 38-year-old man with alcohol use disorder who is highly motivated to quit; his partner has agreed to directly supervise his daily medication intake.
A 26-year-old woman with opioid use disorder who is 14 weeks pregnant and seeking medication-assisted maintenance treatment.
A 48-year-old man admitted for acute alcohol withdrawal who has laboratory evidence of severe alcoholic hepatitis.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align the patient's specific comorbidities with the pharmacokinetic profiles and mechanisms of action of the indicated substance use disorder medications.
Each correct pairing reflects the safest and most effective pharmacotherapy based on the patient's underlying physiology, ensuring that drugs with hepatic metabolism are avoided in liver disease, and renally cleared drugs are avoided in kidney disease.

Adım Adım Çözüm

1
Analyze the comorbidities for the patient with decompensated cirrhosis.
Identify acamprosate as the safe agent, which modulates glutamate at NMDA receptors.
Hepatotoxic drugs like naltrexone must be avoided in liver failure.
2
Analyze the comorbidities for the patient with end-stage renal disease.
Identify naltrexone as the safe agent, which acts as a competitive mu-opioid antagonist.
Renally cleared drugs like acamprosate are absolutely contraindicated in severe renal impairment.
3
Identify the ideal scenario for disulfiram prescription.
Match with the highly motivated patient who has supervised daily administration.
Disulfiram irreversibly inhibits aldehyde dehydrogenase but suffers from poor adherence without supervision.
4
Select the appropriate maintenance therapy for opioid use disorder in pregnancy.
Match with buprenorphine, a partial mu-opioid agonist.
Buprenorphine and methadone are the standards of care to prevent maternal withdrawal and optimize fetal outcomes.
5
Determine the safest withdrawal management in severe acute alcoholic hepatitis.
Match with lorazepam/oxazepam, which are GABA-A modulators lacking active metabolites.
Long-acting benzodiazepines accumulate dangerously in severe liver disease.

Anahtar Kavram

Pharmacotherapy for substance use disorders requires tailoring the specific drug's mechanism of action and pharmacokinetic profile to the patient's underlying comorbidities.
Soru 565Soru →

A 48-month-old boy presents for pediatric evaluation at the urging of his early childhood educator. The educator expressed strong concerns regarding potential Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD). According to the school's behavioral report, the child is unable to sit quietly during a 45-minute continuous group reading session, frequently fidgets, and often engages in parallel play alongside his peers rather than joining their cooperative group games. The parents report that at home, he speaks in 4-word sentences, consistently uses pronouns correctly, and enjoys pedaling his tricycle. During the clinic visit, the child successfully copies a cross on a piece of paper but is unable to copy a triangle. He demonstrates robust, reciprocal eye contact and uses index finger pointing to indicate interest in toys across the room. Based on this clinical presentation, which of the following statements are correct? (Select all that apply)

Geçerli olan tümünü seçin

Cevabı ve açıklamayı göster

Cevap: The child's inability to copy a triangle and his current play patterns are consistent with age-appropriate neurodevelopment.; The child's difficulty sustaining focus during the 45-minute reading session reflects a developmentally normal attention span rather than a primary psychiatric pathology.

Cevap

The correct statements correctly identify that both the child's motor/social skills and his attention span are entirely consistent with normal 4-year-old development.
The correct answers accurately reflect normative pediatric development. At 48 months (4 years) of age, standard developmental milestones include hopping on one foot, pedaling a tricycle, copying a cross (but not a triangle, which is age 5), speaking in 4-to-5 word sentences, and using pronouns correctly. Socially, while cooperative play begins to emerge, parallel play remains highly prevalent and entirely normal. Furthermore, a general rule for pediatric attention span is 2 to 5 minutes per year of age; thus, a 4-year-old can be expected to focus for roughly 8 to 20 minutes. The educator's expectation of 45 minutes of quiet sitting is developmentally inappropriate, meaning the child's fidgeting and 'inattention' are normal physiological responses to the environment, not a manifestation of Attention-Deficit/Hyperactivity Disorder.

Adım Adım Çözüm

1
Analyze the patient's language and motor milestones relative to his chronological age of 48 months (4 years).
Pedaling a tricycle (age 3), speaking in 4-word sentences (age 4), using pronouns correctly (age 4), and copying a cross (age 4) are all developmentally appropriate. Copying a triangle is a 5-year milestone.
Accurate milestone assessment prevents pathologizing normal developmental limitations.
2
Evaluate the educator's behavioral concerns against expected, age-appropriate attention spans and normative social play behaviors.
A 4-year-old's normal attention span is roughly 8 to 20 minutes. A 45-minute continuous reading session is an inappropriate expectation. Furthermore, parallel play frequently persists into age 4 and is not inherently pathological.
Environmental expectations that exceed physiological developmental capacities often mimic psychiatric pathology (like ADHD).
3
Assess the clinical picture for primary neurodevelopmental disorders such as Autism Spectrum Disorder.
The presence of robust, reciprocal eye contact, joint attention (pointing), and normal language development make ASD highly unlikely.
Core deficits in ASD involve impaired social communication and restricted/repetitive behaviors, which are absent here.

Anahtar Kavram

Differentiating normal pediatric development and physiological behavioral variations from early-onset neurodevelopmental disorders.
Tahmini Süre:1m 30s
Soru 566Soru →

A 35-year-old woman is brought to the clinic by her husband for a follow-up appointment. Two weeks ago, she was prescribed sertraline 50 mg daily for a 2-month history of pervasive sadness, sleeping 12 hours a day, a heavy sensation in her extremities, and a 10-lb weight gain following the sudden death of her father. Today, she reports no improvement in her mood and asks to stop the antidepressant because "two weeks is long enough to know it is not working."

She has a history of a pituitary microadenoma treated with transsphenoidal resection 3 years ago, for which she takes levothyroxine. She also takes a daily over-the-counter St. John's wort supplement. Upon further questioning, her husband notes that during college, the patient had a distinct 6-day period where she slept only 2 hours a night, spoke extremely rapidly, and maxed out her credit cards. She also mentions hearing her deceased father's voice calling her name once a few days ago.

Vital signs are within normal limits. Laboratory studies show:

TestResultReference Range
Thyroid-stimulating hormone (TSH)0.2 µU/mL0.4-4.0 µU/mL
Free thyroxine (T4)0.6 ng/dL0.9-1.7 ng/dL

Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Cross-taper sertraline to quetiapine and discontinue St. John's wort

Cevap

Cross-taper sertraline to quetiapine and discontinue St. John's wort
The patient's presentation of a major depressive episode combined with a history of a distinct hypomanic episode (lasting at least 4 days with decreased need for sleep, rapid speech, and impulsivity) establishes a diagnosis of Bipolar II disorder. In bipolar depression, SSRI monotherapy is contraindicated due to the risk of inducing a manic switch. The most appropriate pharmacotherapy includes withdrawing the SSRI and initiating a medication approved for bipolar depression, such as quetiapine. Furthermore, St. John's wort must be discontinued because its concurrent use with an SSRI poses a significant risk for serotonin syndrome, and as a CYP3A4 inducer, it would subtherapeutically lower quetiapine levels.

Adım Adım Çözüm

1
Evaluate the patient's psychiatric history to establish a correct diagnosis.
The patient has a current major depressive episode with atypical features, plus a history of a 6-day hypomanic episode (decreased sleep, rapid speech, impulsivity). This confirms a diagnosis of Bipolar II disorder.
Differentiating unipolar from bipolar depression is critical before managing antidepressant therapy.
2
Assess the safety of the current pharmacologic regimen.
The patient is on an SSRI (sertraline) and St. John's wort. This combination poses a high risk for serotonin syndrome.
Both agents possess strong serotonergic activity and must not be used concurrently.
3
Determine the appropriate psychopharmacological intervention.
SSRI monotherapy is contraindicated in bipolar depression due to the risk of mood destabilization. A transition to an approved bipolar depression agent (e.g., quetiapine, lurasidone) is required.
Although the patient wants to stop the drug prematurely due to 'lack of efficacy' at 2 weeks, stopping it is actually the correct medical decision due to the bipolar diagnosis and interaction risks.
4
Interpret the thyroid function tests in the context of her surgical history.
Both TSH and Free T4 are low. In a patient with prior transsphenoidal resection, this indicates central hypothyroidism where she is under-replaced.
TSH is unreliable in pituitary disease; the low Free T4 dictates management (she needs more levothyroxine, not less).

Anahtar Kavram

Patients presenting with a depressive episode must be screened for a history of mania/hypomania; Bipolar depression requires mood-stabilizing agents (e.g., quetiapine) rather than SSRI monotherapy, and concurrent use of multiple serotonergic agents (like St. John's wort) must be avoided.
Tahmini Süre:1m 30s
Soru 567Soru →

A 34-year-old female software developer comes to the physician's office with her husband. She reports feeling profoundly sad and exhausted for the past month. The patient states she has no energy, sleeps up to 12 hours daily, and struggles to concentrate on her programming tasks. Two weeks ago, her primary care provider diagnosed her with major depressive disorder and prescribed fluoxetine. However, she states her mood has not improved and she now feels increasingly restless. During the interview, her husband notes that three years ago, the patient had a discrete 6-day period where she was unusually energetic, required only three hours of sleep per night, spoke very rapidly, and compulsively reorganized their entire home. She did not require hospitalization at that time and returned to her normal baseline afterward. Her past medical history is unremarkable. Vital signs are within normal limits. Laboratory studies reveal a serum thyroid-stimulating hormone (TSH) level of 1.8 µU/mL and a free T4 of 1.2 ng/dL. On mental status examination, she exhibits psychomotor retardation and a flat affect. Which of the following is the most appropriate next step in pharmacotherapy for this patient?

Cevabı ve açıklamayı göster

Cevap: Discontinue fluoxetine and initiate lithium

Cevap

Discontinue fluoxetine and initiate lithium
The patient's current presentation of a major depressive episode, combined with a history of a distinct 6-day period of elevated mood, decreased sleep, and increased goal-directed activity, confirms a diagnosis of bipolar II disorder. The prior provider misdiagnosed her with major depressive disorder and prescribed fluoxetine (an SSRI). Antidepressant monotherapy is generally contraindicated in patients with bipolar disorder due to the significant risk of precipitating a hypomanic or manic switch. The most appropriate next step is to immediately discontinue the offending antidepressant and initiate a medication approved for bipolar depression, such as lithium, quetiapine, or lurasidone.

Adım Adım Çözüm

1
Identify the patient's current clinical presentation.
The patient is experiencing a major depressive episode, currently treated with fluoxetine monotherapy.
Establishing the current affective state is the first step in psychiatric management.
2
Analyze the collateral history provided by the husband.
The history of a distinct 6-day period of elevated energy, decreased need for sleep, and rapid speech indicates a past hypomanic episode.
A history of hypomania changes the primary diagnosis from major depressive disorder to bipolar II disorder.
3
Evaluate the safety and efficacy of the current treatment regimen.
Fluoxetine is an antidepressant monotherapy, which carries a high risk of inducing a manic or hypomanic switch in patients with bipolar disorder.
Antidepressant monotherapy is generally contraindicated in bipolar disorder.
4
Determine the safest and most appropriate pharmacologic intervention.
The SSRI must be stopped, and an approved mood stabilizer or atypical antipsychotic (such as lithium) should be initiated to treat bipolar depression.
Lithium effectively treats bipolar depression and provides prophylaxis against future mood episodes without the risk of manic switching.

Anahtar Kavram

Patients presenting with depressive symptoms must be carefully screened for a history of mania or hypomania; if bipolar disorder is diagnosed, antidepressant monotherapy should be avoided and a mood stabilizer should be initiated.
Soru 568Soru →

A 5252-year-old man is brought to the emergency department by emergency medical services after being found somnolent in a park. He has a documented history of severe alcohol use disorder and has been unhoused for the past year. On initial evaluation, he is lethargic but easily rousable. Vital signs reveal a temperature of 35.8∘C35.8^\circ\text{C} (96.4∘F96.4^\circ\text{F}), blood pressure of 105/60 mmHg105/60\text{ mmHg}, pulse of 112/min112/\text{min}, and respiratory rate of 14/min14/\text{min}. A point-of-care blood glucose level is 52 mg/dL52\text{ mg/dL}. Over the next hour, he becomes increasingly awake but is agitated, profoundly diaphoretic, and exhibits bilateral action tremors of his hands. Arrange the following clinical interventions in the most appropriate sequential order for the comprehensive management of this patient, from initial emergency presentation through hospital discharge.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The optimal clinical sequence is: Assessment of airway patency, breathing, and circulation → Administration of intravenous thiamine → Administration of intravenous dextrose → Administration of symptom-triggered intravenous lorazepam → Prescription of oral naltrexone and referral to addiction counseling.
The correct sequence ensures patient safety by prioritizing immediate life threats and preventing iatrogenic harm. The airway is always assessed first. Hypoglycemia must be corrected next, but because glucose metabolism rapidly depletes thiamine, thiamine must be given first or concurrently to prevent Wernicke encephalopathy. Acute withdrawal symptoms (tremors, agitation) are treated next with benzodiazepines to prevent seizures. Finally, long-term outpatient management with naltrexone is planned prior to discharge.

Adım Adım Çözüm

1
Perform primary survey (ABCs).
Ensures the patient is protecting his airway and maintains adequate perfusion.
Any patient presenting with an altered level of consciousness requires immediate assessment of basic life-sustaining functions before diagnostic or secondary therapeutic interventions.
2
Administer intravenous thiamine.
Replenishes a critical coenzyme required for carbohydrate metabolism.
In individuals with severe alcohol use disorder, malnutrition frequently causes thiamine deficiency. Thiamine must be given prior to or alongside glucose to prevent precipitating Wernicke encephalopathy.
3
Administer intravenous dextrose.
Rapidly corrects the documented hypoglycemia (52 mg/dL52\text{ mg/dL}).
Hypoglycemia is a life-threatening metabolic derangement that must be corrected immediately after securing the airway and providing thiamine.
4
Initiate symptom-triggered benzodiazepines (e.g., lorazepam).
Controls emergent agitation, diaphoresis, and tremors.
As the patient awakens, he exhibits classic signs of early alcohol withdrawal. Benzodiazepines suppress the hyperactive central nervous system, preventing withdrawal seizures and delirium tremens.
5
Prescribe maintenance pharmacotherapy and counseling.
Reduces alcohol cravings and supports long-term abstinence.
Once the acute life-threats and withdrawal phases are resolved, comprehensive discharge planning using medications like naltrexone and behavioral therapy is the standard of care for substance use disorders.

Anahtar Kavram

The management of patients with severe alcohol use disorder presenting with altered mental status requires a strict sequence: initial ABC stabilization, administration of thiamine prior to or with dextrose to prevent Wernicke encephalopathy, symptom-triggered benzodiazepines for withdrawal, and finally, maintenance pharmacotherapy for relapse prevention.
Soru 569Soru →

A 28-year-old man is brought to the emergency department by his husband due to worsening fatigue, dizziness, and a recent syncopal episode. He is a competitive marathon runner who has been rigorously restricting his caloric intake for the past eight months to 'improve race times.' He reports an intense fear of gaining weight and strictly avoids any foods containing fat. Temperature is 35.4°C (95.7°F), blood pressure is 82/50 mm Hg, pulse is 38/min, and respirations are 12/min. BMI is 13.2 kg/m². Physical examination reveals temporal wasting, fine downy hair over his back, and cold, cyanotic extremities. Laboratory studies show:

TestResultReference Range
Potassium3.1 mEq/L3.5-5.0 mEq/L
Phosphorus2.2 mg/dL2.5-4.5 mg/dL
Magnesium1.4 mg/dL1.7-2.2 mg/dL

An ECG reveals marked sinus bradycardia with a QTc interval of 490 ms. The patient is admitted to the hospital. Arrange the following multidisciplinary management steps in the most appropriate chronological order, from immediate acute intervention to long-term maintenance.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence prioritizes acute medical stabilization (telemetry and electrolyte correction), followed by cautious prevention of refeeding syndrome during initial nutrition, then inpatient psychiatric behavioral modification, and finally long-term outpatient psychotherapy.
The proper management of severe anorexia nervosa dictates that life-threatening physical derangements take absolute precedence over psychological treatment. This patient requires admission to a medical unit with telemetry to manage his bradycardia and QTc prolongation while correcting his baseline electrolyte deficits. Once telemetry is established, cautious enteral feeding is initiated to avoid refeeding syndrome. Only after he is medically stable (normalizing vital signs and electrolytes) should he be transferred to an inpatient psychiatric unit for structured behavioral interventions. Finally, long-term outpatient CBT is utilized to address the underlying psychopathology and prevent relapse.

Adım Adım Çözüm

1
Identify the severity of the patient's presentation and recognize criteria for medical admission.
The patient has severe anorexia nervosa with criteria for immediate medical hospitalization (BMI <15, bradycardia <40/min, hypotension <90/60 mm Hg, hypothermia <35°C, and QTc prolongation).
Recognizing life-threatening medical complications dictates that psychiatric interventions must be deferred until the patient is physiologically stable.
2
Determine the sequence of inpatient medical management.
Cardiac monitoring (telemetry) and correction of baseline hypokalemia and hypophosphatemia must precede the introduction of calories.
Feeding a severely malnourished patient with existing electrolyte derangements exponentially increases the risk of fatal refeeding syndrome.
3
Determine the transition from medical to psychiatric care.
Structured behavioral programs and supervised meals begin in a psychiatric unit only after medical clearance.
Psychiatric units generally lack the capability to manage acute hemodynamic instability or cardiac arrhythmias.
4
Determine the long-term maintenance strategy.
Outpatient cognitive-behavioral therapy (CBT) is established post-discharge.
CBT is the most effective long-term intervention for changing the core distorted beliefs regarding body image in adult patients.

Anahtar Kavram

The management of severe anorexia nervosa requires a sequential approach: acute medical stabilization and continuous cardiac monitoring first, cautious nutritional rehabilitation to prevent refeeding syndrome second, inpatient psychiatric behavioral modification third, and long-term outpatient psychotherapy finally.
Soru 570Soru →

A 22-year-old man is brought to the emergency department by his college roommates after he began acting erratically and destroying furniture in their apartment. His roommates suspect he ingested a synthetic hallucinogen at a party earlier in the evening. In the evaluation room, the patient exhibits severe psychomotor agitation, rapid pacing, and hostility, loudly threatening to 'break out' of the hospital. He aggressively waves off the nurse who attempts to obtain vital signs.

Arrange the following interventions in the most appropriate sequential order for managing this patient's acute agitation, progressing from the least restrictive to the most restrictive measure.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is to first ensure environmental safety, second attempt verbal de-escalation, third offer voluntary oral medications, fourth administer involuntary intramuscular medications, and finally apply physical restraints as a last resort.
The management of acute agitation in the psychiatric setting strictly adheres to the principle of the least restrictive alternative. The sequence begins with non-invasive measures: securing the environment to prevent immediate harm, followed closely by verbal de-escalation to build rapport and calm the patient. If these behavioral interventions fail, the next least restrictive step is offering voluntary oral medications, which respects patient autonomy while addressing the underlying neurochemical disturbance. Only when a patient refuses oral treatment and remains an acute threat to themselves or others should involuntary chemical restraints (intramuscular injections) be administered. Finally, mechanical physical restraints are the most restrictive intervention and are reserved exclusively for situations where chemical restraints are ineffective, refused in a highly dangerous scenario, or cannot be safely administered, and there is an imminent risk of severe harm.

Adım Adım Çözüm

1
Identify the primary ethical and clinical goal
The goal is to manage acute agitation using the principle of the least restrictive alternative.
Medical ethics and legal guidelines mandate that patients be treated in the least restrictive setting possible to preserve autonomy and minimize trauma.
2
Determine the initial non-pharmacologic interventions
Environmental safety measures and verbal de-escalation must occur first.
Safety is paramount, and non-invasive verbal techniques can often de-escalate a crisis without the need for medication or force.
3
Determine the pharmacologic progression
Voluntary oral medications must precede involuntary intramuscular medications.
Oral medications preserve patient autonomy. Forcible injections (chemical restraints) are only justified when voluntary measures are refused and the patient poses an ongoing risk.
4
Identify the absolute last resort intervention
Mechanical physical restraints are placed last in the sequence.
Physical restraints carry significant psychological trauma and physical risks (e.g., asphyxiation, rhabdomyolysis) and are only used when all other less restrictive measures have failed to mitigate imminent harm.

Anahtar Kavram

Management of the acutely agitated psychiatric patient strictly follows a stepwise escalation protocol based on the legal and ethical principle of the least restrictive alternative.
Tahmini Süre:1m 15s
Soru 571Soru →

Evaluate the following clinical scenarios of patients presenting with depressive symptoms. Match each patient's clinical presentation with the most suitable treatment modality based on their specific features and comorbidities.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 22-year-old man with a current severe depressive episode. His history includes a distinct 5-day period of elevated mood, decreased need for sleep, and excessive spending.
A 34-year-old man seeking treatment for low energy and poor concentration. He smokes a pack of cigarettes daily and requests a medication that aids in smoking cessation while avoiding sexual side effects.
A 78-year-old woman hospitalized for severe dehydration secondary to depression with delusions of poverty. She is mute and refuses all oral intake.
A 52-year-old man with pervasive sadness and anhedonia, alongside poorly controlled type 2 diabetes mellitus complicated by bilateral burning foot pain.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match each patient's specific clinical features and comorbidities with the targeted therapeutic profile of the intervention.
Each clinical scenario presents a patient with depressive symptoms complicated by specific features or comorbidities. Quetiapine is appropriate for bipolar depression. Bupropion addresses both depression and tobacco use without sexual side effects. Electroconvulsive therapy is the treatment of choice for depression with life-threatening food refusal and psychosis. Duloxetine simultaneously targets both depression and painful diabetic neuropathy.

Adım Adım Çözüm

1
Identify the diagnosis and treatment needs for the 22-year-old man.
Diagnosis is bipolar II disorder, currently depressed.
The history of a 5-day hypomanic episode precludes a diagnosis of unipolar depression and necessitates treatment with a mood stabilizer or atypical antipsychotic like quetiapine.
2
Analyze the specific preferences and comorbidities of the 34-year-old man.
Requires treatment for depression that also aids in smoking cessation and lacks sexual side effects.
Bupropion meets all these specific criteria due to its dopaminergic and noradrenergic activity without serotonergic sexual side effects.
3
Evaluate the acuity and severity of the 78-year-old woman's presentation.
Major depressive disorder with psychotic features and life-threatening food refusal.
Electroconvulsive therapy provides the rapid, definitive response required for life-threatening inanition and psychosis.
4
Assess the medical comorbidities of the 52-year-old man.
Major depressive disorder with concurrent painful diabetic neuropathy.
Duloxetine is indicated for both depression and neuropathic pain, offering dual benefit.

Anahtar Kavram

Individualizing treatment for depressive disorders based on comorbidities, symptom severity, and specific patient preferences.
Soru 572Soru →

A 27-year-old female is evaluated in the emergency department for severe fatigue, generalized muscle weakness, and palpitations. She has a history of major depressive disorder and a long-standing intense fear of gaining weight. She exercises vigorously for 2 hours daily and adheres to a strict diet. Her body mass index is 22.0 kg/m222.0 \text{ kg/m}^2. She denies self-induced vomiting but admits to secretly taking "herbal bowel cleansers" containing senna extract multiple times a day for the past year to prevent weight gain. Vital signs are temperature 37.0°C (98.6°F), blood pressure 95/60 mm Hg, pulse 112/min, and respiratory rate 12/min. Physical examination reveals dry oral mucosa and diffusely decreased muscle strength in all extremities. Electrocardiogram shows flattened T waves and prominent U waves.

Laboratory studies:
Sodium: 135 mEq/L135 \text{ mEq/L}
Potassium: 2.4 mEq/L2.4 \text{ mEq/L}
Chloride: 115 mEq/L115 \text{ mEq/L}
Bicarbonate: 12 mEq/L12 \text{ mEq/L}
Blood urea nitrogen: 28 mg/dL28 \text{ mg/dL}
Creatinine: 1.1 mg/dL1.1 \text{ mg/dL}

Arterial blood gas analysis on room air:
pH: 7.27
pCO2pCO_2: 38 mm Hg
pO2pO_2: 94 mm Hg

Based on the clinical and laboratory findings, which of the following best describes this patient's acid-base status?

Cevabı ve açıklamayı göster

Cevap: Normal anion gap metabolic acidosis with a concurrent respiratory acidosis

Cevap

Normal anion gap metabolic acidosis with a concurrent respiratory acidosis
This patient presents with a purging-type eating disorder utilizing severe laxative abuse. Laxatives cause significant gastrointestinal loss of potassium and bicarbonate, classically leading to a hypokalemic normal anion gap metabolic acidosis (NAGMA). Her anion gap is calculated as Na+−(Cl−+HCO3−)=135−(115+12)=8 mEq/LNa^+ - (Cl^- + HCO_3^-) = 135 - (115 + 12) = 8 \text{ mEq/L}, which is well within normal limits. To assess for mixed acid-base disorders in metabolic acidosis, Winter's formula must be applied: Expected pCO2=(1.5×[HCO3−])+8±2pCO_2 = (1.5 \times [HCO_3^-]) + 8 \pm 2. For this patient, the expected pCO2=(1.5×12)+8=26±2 mm HgpCO_2 = (1.5 \times 12) + 8 = 26 \pm 2 \text{ mm Hg}. Because her measured pCO2pCO_2 (38 mm Hg) is significantly higher than the expected range (24-28 mm Hg), she is hypoventilating relative to her metabolic state, indicating a concurrent primary respiratory acidosis. This hypoventilation (respiratory rate 12/min) is a direct consequence of her profound hypokalemia (2.4 mEq/L2.4 \text{ mEq/L}), which causes generalized muscle weakness, including the respiratory muscles.

Adım Adım Çözüm

1
Analyze the pH and bicarbonate levels to determine the primary disorder.
pH is 7.27 (acidemia) and bicarbonate is low (12 mEq/L12 \text{ mEq/L}), confirming a primary metabolic acidosis.
Establishing the primary acid-base disturbance is the required first step before calculating gaps or compensation.
2
Calculate the serum anion gap using the formula: Na+−(Cl−+HCO3−)Na^+ - (Cl^- + HCO_3^-).
135−(115+12)=135−127=8 mEq/L135 - (115 + 12) = 135 - 127 = 8 \text{ mEq/L}. The anion gap is normal (reference range 8-12 mEq/L).
Differentiating between normal and high anion gap metabolic acidosis narrows the differential diagnosis (e.g., GI bicarbonate loss vs. ketoacidosis).
3
Apply Winter's formula to calculate the expected pCO2pCO_2: Expected pCO2=(1.5×[HCO3−])+8±2pCO_2 = (1.5 \times [HCO_3^-]) + 8 \pm 2.
Expected pCO2=(1.5×12)+8=18+8=26±2 mm HgpCO_2 = (1.5 \times 12) + 8 = 18 + 8 = 26 \pm 2 \text{ mm Hg}.
Winter's formula determines if the respiratory system is adequately compensating for the metabolic acidosis.
4
Compare the measured pCO2pCO_2 to the expected pCO2pCO_2 range.
The measured pCO2pCO_2 is 38 mm Hg, which is significantly higher than the expected range of 24-28 mm Hg. This indicates a concurrent primary respiratory acidosis.
An inappropriately high pCO2pCO_2 in the setting of metabolic acidosis defines a mixed disorder (concurrent respiratory acidosis), which in this case is caused by hypokalemia-induced respiratory muscle weakness.

Anahtar Kavram

Patients with eating disorders who abuse laxatives develop a normal anion gap metabolic acidosis (due to GI bicarbonate loss), which can be complicated by respiratory acidosis if severe hypokalemia causes hypoventilation.
Tahmini Süre:1m 30s
Soru 573Soru →

A 34-year-old male with a history of treatment-resistant schizophrenia is hospitalized for the management of severe lower extremity cellulitis. His daily psychiatric regimen includes clozapine 400 mg daily, which has successfully managed his psychotic symptoms for the past two years without major adverse effects. The patient has a 15-pack-year smoking history and typically smokes two packs of cigarettes daily. Because the hospital is a strict tobacco-free facility, he is prescribed a continuous 21-mg nicotine transdermal patch upon admission to prevent withdrawal. On hospital day 4, the nursing staff notes that the patient is profoundly sedated, confused, and experiencing excessive drooling. Later that afternoon, he suffers a witnessed generalized tonic-clonic seizure. Vital signs reveal a blood pressure of 100/60 mmHg and a heart rate of 112/min. Laboratory studies show a leukocyte count of 7,500/mm³ and a normal basic metabolic panel. Which of the following pharmacological mechanisms is the most likely primary cause of this patient's acute neurological complication?

Cevabı ve açıklamayı göster

Cevap: Loss of cytochrome P450 enzyme induction

Cevap

The most likely cause of the patient's acute presentation is the loss of cytochrome P450 enzyme induction due to smoking cessation.
The patient's presentation of a new-onset generalized tonic-clonic seizure, profound sedation, sialorrhea (excessive drooling), and hypotension is highly characteristic of acute clozapine toxicity. Clozapine is an atypical antipsychotic that is extensively metabolized by the hepatic enzyme cytochrome P450 1A2 (CYP1A2). Tobacco smoke contains polycyclic aromatic hydrocarbons (PAHs), which are potent inducers of CYP1A2. When a heavy smoker is admitted to a smoke-free hospital, the abrupt cessation of PAH exposure leads to a rapid loss of CYP1A2 induction. Consequently, the previously established home dose of clozapine is no longer metabolized at the same accelerated rate, causing its serum concentration to spike dramatically. High serum levels of clozapine are directly associated with dose-dependent toxicities, including a significantly increased risk of seizures. Importantly, while nicotine replacement therapy (such as the transdermal patch) effectively treats nicotine withdrawal cravings, it does not contain the PAHs found in combustible tobacco, meaning it cannot maintain the crucial CYP1A2 induction.

Adım Adım Çözüm

1
Analyze the patient's acute clinical presentation.
The patient developed new-onset generalized tonic-clonic seizures, profound sedation, sialorrhea (drooling), hypotension, and tachycardia.
Identifying the clinical syndrome is essential for recognizing it as acute clozapine toxicity, which has a known dose-dependent risk of seizures.
2
Review the patient's medication and environmental changes upon hospitalization.
The patient was maintained on clozapine but transitioned from heavy cigarette smoking (2 packs per day) to a nicotine transdermal patch.
Environmental and therapeutic shifts during transitions of care often trigger adverse pharmacological events.
3
Recall the pharmacokinetic relationship between smoking, clozapine, and the prescribed alternative.
Polycyclic aromatic hydrocarbons (PAHs) in tobacco smoke strongly induce CYP1A2. Nicotine replacement therapy provides nicotine but lacks PAHs, failing to maintain this induction.
Understanding the specific metabolic pathway differentiates the effects of the actual tobacco smoke from the chemical effects of nicotine.
4
Synthesize the mechanism to explain the outcome.
Abrupt cessation of PAHs leads to a rapid loss of CYP1A2 induction. The standard home dose of clozapine (a major CYP1A2 substrate) is no longer rapidly metabolized, causing serum levels to spike into the toxic range and trigger dose-dependent seizures.
This confirms that the loss of induction is the primary mechanism driving the patient's neurological complication.

Anahtar Kavram

Polycyclic aromatic hydrocarbons in tobacco smoke strongly induce cytochrome P450 1A2 (CYP1A2). Abrupt smoking cessation in a patient on a stable dose of a CYP1A2 substrate (like clozapine) causes a rapid loss of induction, leading to toxic serum drug levels. Nicotine patches do not contain hydrocarbons and will not prevent this interaction.
Soru 574Soru →

A 29-year-old man comes to the psychiatry clinic seeking help for distressing mental images. For the past 3 months, he has experienced recurrent, intrusive thoughts of violently harming strangers. He finds these images horrifying and states, "I would never do such a thing, but I just can't stop the thoughts." To temporarily relieve his anxiety, he taps his forehead exactly 15 times whenever an image appears. His psychiatric history is notable for treatment-resistant depression, for which he was prescribed phenelzine 2 years ago with a good response. A review of his electronic medical record reveals a 5-day episode last year characterized by grandiosity, a decreased need for sleep, rapid speech, and hypersexuality. The patient is employed as an accountant. His manager recently left a voicemail at the clinic requesting a medical update because the patient has been taking frequent breaks. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Refer the patient for exposure and response prevention therapy

Cevap

Refer the patient for exposure and response prevention therapy
The correct answer is to refer the patient for exposure and response prevention therapy. The patient's presentation of recurrent, intrusive, ego-dystonic thoughts relieved by repetitive physical acts is diagnostic of obsessive-compulsive disorder (OCD). First-line treatments for OCD include cognitive-behavioral therapy specifically focused on exposure and response prevention (ERP) and/or serotonergic antidepressants (SSRIs or clomipramine). In this patient, pharmacotherapy is complicated by two major factors. First, he is taking phenelzine, a monoamine oxidase inhibitor (MAOI); concomitant use of an MAOI and a serotonergic medication is contraindicated due to the risk of life-threatening serotonin syndrome. Second, he has a history of a hypomanic episode (5 days of grandiosity, decreased sleep, rapid speech), indicating an underlying Bipolar II disorder. Initiating antidepressant monotherapy in a patient with bipolar disorder carries a high risk of inducing a manic switch. Therefore, a non-pharmacologic approach using ERP therapy is the safest and most effective next step.

Adım Adım Çözüm

1
Identify the primary psychiatric diagnosis based on the clinical presentation.
The patient has recurrent, intrusive, ego-dystonic thoughts (obsessions) and engages in repetitive tapping (compulsions) to relieve anxiety, establishing a diagnosis of Obsessive-Compulsive Disorder (OCD).
An accurate primary diagnosis is required to select the appropriate evidence-based therapy.
2
Analyze the patient's psychiatric and medication history for potential contraindications to standard OCD pharmacotherapy.
The patient has a history of a 5-day hypomanic episode (indicating Bipolar II disorder) and is currently taking phenelzine (an MAOI).
Comorbidities and current medications dictate the safety profile of potential treatments, particularly ruling out serotonergic antidepressants without a washout and identifying the risk of a manic switch.
3
Select the safest first-line treatment for OCD in this specific clinical context.
Exposure and response prevention (ERP) therapy is selected.
ERP is a definitive first-line OCD treatment that entirely avoids the risk of serotonin syndrome and mood destabilization.

Anahtar Kavram

First-line treatment for Obsessive-Compulsive Disorder (OCD) includes Exposure and Response Prevention (ERP) therapy, which is especially indicated when pharmacotherapy (SSRIs or clomipramine) is contraindicated due to drug interactions (e.g., MAOIs) or comorbid bipolar disorder.
Tahmini Süre:1m 30s
Soru 575Soru →

A 23-year-old woman comes to the outpatient psychiatric clinic for a follow-up appointment. Five months ago, she experienced the sudden onset of auditory hallucinations and persecutory delusions, believing that her university professors were conspiring to harm her. These symptoms began abruptly three days after she was involved in a severe motor vehicle collision. She was hospitalized and started on oral aripiprazole. Her psychotic symptoms completely resolved 3 weeks after they initially began. She was subsequently discharged and has been taking aripiprazole daily. She has had no recurrence of symptoms for the past 4 months, and her academic and social functioning have returned entirely to their premorbid baseline. She is bothered by mild weight gain and asks how much longer she must continue taking the medication. What is the most appropriate next step in the management of this patient's pharmacotherapy?

Cevabı ve açıklamayı göster

Cevap: Taper and discontinue the medication over the next few weeks

Cevap

Taper and discontinue the medication over the next few weeks
The most appropriate next step is to taper and discontinue the antipsychotic medication. This patient's clinical presentation—sudden onset of hallucinations and delusions following a stressor, with complete symptom resolution within 1 month and a full return to baseline functioning—is diagnostic of brief psychotic disorder. According to standard psychiatric guidelines, antipsychotic medication for brief psychotic disorder should be continued for 1 to 3 months after symptom remission to ensure clinical stability. Because this patient has been entirely asymptomatic for 4 months, she has safely completed the maintenance phase. The medication should now be gradually tapered to minimize withdrawal effects and the risk of relapse, which will also resolve her medication-induced weight gain.

Adım Adım Çözüm

1
Determine the total duration of the patient's active psychotic symptoms and overall illness course.
The psychotic symptoms began abruptly and resolved completely within 3 weeks.
Symptom duration is the primary differentiator between various primary psychotic disorders.
2
Establish the most likely diagnosis based on symptom duration and functional recovery.
The diagnosis is brief psychotic disorder with a marked stressor.
Brief psychotic disorder is characterized by psychotic symptoms lasting between 1 day and 1 month, followed by a full return to the premorbid level of functioning.
3
Identify the standard pharmacological maintenance guidelines for the diagnosed condition.
Antipsychotic therapy should be tapered after 1 to 3 months of symptom remission.
Because the patient has been asymptomatic for 4 months, she has completed the recommended maintenance phase, and the medication should now be discontinued.

Anahtar Kavram

Pharmacological management and maintenance timeline of brief psychotic disorder
Soru 576Soru →

Match each mood stabilizer or second-generation antipsychotic used in the management of bipolar disorder with its most characteristic adverse effect profile, baseline monitoring requirement, or presentation of toxicity.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Lithium
Valproate
Lamotrigine
Quetiapine

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Lithium corresponds to NSAID interactions and coarse tremors. Valproate corresponds to hepatotoxicity and thrombocytopenia. Lamotrigine corresponds to slow titration to avoid severe rash. Quetiapine corresponds to metabolic syndrome monitoring.
Matching mood stabilizers to their profiles tests essential pharmacologic knowledge. Lithium causes neurologic toxicity exacerbated by renally active drugs. Valproate is hepatotoxic and suppresses platelets. Lamotrigine requires slow titration due to severe rash risk. Quetiapine commonly induces metabolic derangements.

Adım Adım Çözüm

1
Evaluate the clinical properties of lithium.
Lithium requires renal and thyroid monitoring; toxicity is characterized by coarse tremors and is worsened by NSAIDs and thiazides.
Lithium relies entirely on the kidneys for clearance.
2
Evaluate the clinical properties of valproate.
Valproate is associated with liver toxicity, thrombocytopenia, and hyperammonemia.
These specific adverse effects require baseline and periodic CBC and LFTs.
3
Evaluate the clinical properties of lamotrigine.
Lamotrigine has a black box warning for Stevens-Johnson syndrome.
This risk is mitigated by a strict, slow titration schedule.
4
Evaluate the clinical properties of quetiapine.
Quetiapine causes significant weight gain and metabolic syndrome.
It is a second-generation antipsychotic with high affinity for histaminergic and cholinergic receptors.

Anahtar Kavram

Pharmacologic management of bipolar disorder: adverse effects and monitoring
Tahmini Süre:1m 30s
Soru 577Soru →

A 68-year-old woman is evaluated in the outpatient clinic for an acute episode of major depressive disorder without psychotic features. Over the course of the next year, her condition proves highly resistant to standard therapies, eventually culminating in severe clinical deterioration. Arrange the following clinical management steps in the correct evidence-based chronological sequence, reflecting the standard escalation of psychiatric care from initial presentation to the eventual onset of life-threatening psychotic depression with severe food refusal.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence of management is: 1. Initiate first-line monotherapy with an SSRI; 2. Switch to a different antidepressant class (e.g., SNRI) after 6 weeks of non-response; 3. Augment the regimen with a second-generation antipsychotic after a partial response; 4. Admit to an acute inpatient psychiatric unit due to new-onset delusions and food refusal; 5. Initiate a course of electroconvulsive therapy (ECT).
The sequence accurately reflects standard USMLE algorithms for escalating depression treatment. Initially, an SSRI is the preferred first-line agent. Complete non-response after an adequate 4-6 week trial prompts a switch to a different agent (e.g., SNRI). If the second agent provides a partial therapeutic response, augmentation (e.g., with aripiprazole or lithium) is appropriate to maximize benefit. If the patient's condition continues to worsen to the point of developing psychotic features or refusing food, outpatient management becomes inherently unsafe, mandating immediate inpatient psychiatric admission. Finally, in the setting of severe psychotic depression with life-threatening food refusal, ECT is the most rapid and effective definitive intervention.

Adım Adım Çözüm

1
Establish first-line treatment for an initial major depressive episode.
Initiate SSRI monotherapy.
SSRIs offer the best balance of efficacy and tolerability for initial outpatient treatment.
2
Address complete non-response at 6 weeks.
Switch to an SNRI.
A 4-6 week duration is an adequate trial. Complete absence of clinical improvement dictates switching to a different medication rather than augmenting.
3
Address partial response to the second antidepressant agent.
Augment with a second-generation antipsychotic.
Augmentation builds upon the partial efficacy achieved, avoiding the loss of gained therapeutic benefits that might occur with another switch.
4
Respond to acute safety risks and clinical decompensation.
Inpatient psychiatric admission.
The new onset of psychosis and food refusal poses an imminent threat to the patient's life, requiring a secure hospital setting for immediate stabilization.
5
Select definitive treatment for life-threatening psychotic depression.
Administer ECT.
ECT provides unmatched speed and efficacy for severe, refractory, or psychotic depression, especially when nutritional status is acutely compromised.

Anahtar Kavram

Stepped-care pharmacological management of Major Depressive Disorder (MDD) and indications for Electroconvulsive Therapy (ECT)
Tahmini Süre:1m 30s
Soru 578Soru →

A 38-year-old male accountant is brought to the outpatient psychiatric clinic by his husband due to a 3-week history of worsening depressed mood, severe fatigue, and anhedonia. He reports sleeping up to 14 hours a day and has gained 5 kg (11 lbs) during this time. The patient states he feels completely hopeless and occasionally wishes he would not wake up in the morning, though he denies any active plan to end his life. When asked about unusual experiences, he mentions that over the past few days, he has occasionally heard his mother's voice calling his name just as he is drifting off to sleep. His psychiatric history is notable for an episode four years ago during which he felt "invincible" for 2 weeks. During that time, he slept only 3 hours per night, spoke incessantly, and impulsively spent his entire life savings on a high-risk cryptocurrency venture, resulting in personal bankruptcy. He was not hospitalized for that episode and currently takes no medications. Vital signs are within normal limits. Laboratory results show a thyroid-stimulating hormone (TSH) level of 1.5 µU/mL (normal: 0.4-4.0 µU/mL) and a free T4 of 1.1 ng/dL (normal: 0.8-1.8 ng/dL). Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Initiate lithium therapy

Cevap

The most appropriate next step in management is to initiate a mood stabilizer such as lithium.
This patient's history of a distinct 2-week period characterized by decreased need for sleep, grandiosity, pressured speech, and severe functional impairment (bankruptcy) meets the criteria for a manic episode. Therefore, his overarching diagnosis is Bipolar I disorder. He is currently presenting with a major depressive episode. The treatment of acute bipolar depression differs significantly from unipolar major depressive disorder. First-line pharmacotherapy for bipolar depression includes mood stabilizers (e.g., lithium) or specific second-generation antipsychotics (e.g., quetiapine, lurasidone, cariprazine). Lithium is highly effective for both treating the acute depressive episode and serving as a maintenance agent to prevent future manic and depressive relapses, as well as reducing the risk of suicide.

Adım Adım Çözüm

1
Analyze the patient's past psychiatric history.
The patient had a 2-week episode of decreased need for sleep, grandiosity, and reckless spending causing bankruptcy (marked impairment).
This confirms a history of a full manic episode, establishing the diagnosis of Bipolar I disorder.
2
Evaluate the current presentation and laboratory findings.
The patient is experiencing a major depressive episode. TSH and free T4 are normal, ruling out secondary or primary hypothyroidism. The auditory hallucination when falling asleep is a hypnagogic hallucination, which is benign.
This clarifies that the current state is acute bipolar depression and eliminates organic causes or primary psychotic disorders.
3
Select the appropriate pharmacotherapy for acute bipolar depression.
Lithium is selected over antidepressant monotherapy.
First-line agents for bipolar depression include lithium, quetiapine, lurasidone, or cariprazine. Standard antidepressants (SSRIs) must be avoided to prevent a manic switch.

Anahtar Kavram

Patients with a history of mania presenting with an acute depressive episode have Bipolar I disorder and must be treated with mood stabilizers or atypical antipsychotics approved for bipolar depression, strictly avoiding antidepressant monotherapy.
Soru 579Soru →

Match each clinical presentation of a patient with an eating or somatic symptom-related disorder to the most characteristic laboratory abnormality or physical finding associated with their condition.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A college student of normal weight who reports cycles of consuming massive amounts of food followed by intentional emesis.
An aspiring dancer who frequently consumes over-the-counter senna and bisacodyl to control her shape, presenting with chronic watery stool.
An adolescent track athlete presenting with severe dietary restriction, a body mass index of 14.2 kg/m², and fine downy body hair.
A laboratory technician with recurrent symptomatic hypoglycemic episodes who secretly self-administers medication to gain medical attention without external reward.
A profoundly malnourished patient who develops acute heart failure and arrhythmias 48 hours after starting aggressive oral and intravenous nutritional supplementation.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Each clinical presentation aligns with a specific pathophysiological consequence: vomiting causes metabolic alkalosis; laxative abuse causes normal anion gap metabolic acidosis; starvation induces hypothalamic amenorrhea and bradycardia; exogenous insulin use suppresses C-peptide; and rapid refeeding shifts electrolytes intracellularly.
Each disorder leads to specific, identifiable clinical and laboratory findings based on its unique mechanism. Self-induced vomiting causes acid loss (alkalosis), while laxative abuse causes bicarbonate loss (acidosis). Severe starvation leads to hormonal suppression and bradycardia. Factitious hypoglycemia from exogenous insulin is proven by suppressed C-peptide, and refeeding syndrome is driven by insulin-mediated intracellular shifts of essential electrolytes.

Adım Adım Çözüm

1
Analyze each patient's clinical presentation to identify the specific psychiatric disorder or behavioral pattern.
Identified behaviors include self-induced vomiting, laxative abuse, severe caloric restriction, surreptitious insulin use, and rapid nutritional replenishment.
Accurate identification of the underlying behavior is necessary to predict the resulting physiological derangements.
2
Determine the metabolic and physical consequences of each identified behavior.
Vomiting depletes acid (alkalosis); laxatives deplete base (acidosis); starvation lowers basal metabolic rate; exogenous insulin acts without C-peptide; and refeeding spikes insulin.
Understanding the mechanism of injury or physiological adaptation links the psychiatric condition to the medical findings.
3
Correlate the determined physiological consequences with the provided laboratory and physical examination findings.
The correct matches are formed based on the direct pathophysiological links between the psychiatric presentation and the medical abnormalities.
This confirms the correct diagnostic differentiation required for accurate clinical assessment.

Anahtar Kavram

Differentiation of eating disorders and somatic symptom-related conditions through their distinct physiological, laboratory, and metabolic consequences.
Soru 580Soru →

A 15-year-old female is brought to the outpatient psychiatric clinic by her parents due to increasing school refusal, irritability, and tearful outbursts over the past six months. She recently started high school and complains that she is "exhausted all the time." When asked to explain, she states, "I have to constantly study how other girls act and rehearse my conversations so I don't seem weird. I never naturally know when it is my turn to speak or what people's facial expressions mean." The patient also reports that the noise and fluorescent lights in the school cafeteria cause her physical pain, prompting her to eat alone in a quiet stairwell. Her parents note that she has an intense, exclusive fascination with 19th-century European royalty, spending several hours daily memorizing genealogical trees. She becomes highly distressed and has "meltdowns" if her rigidly structured evening routine is altered. Her early motor and language milestones were reportedly achieved at appropriate ages, though she was considered a solitary child.

Which of the following best describes the underlying nature of this patient's condition?

Cevabı ve açıklamayı göster

Cevap: An underlying neurodevelopmental disorder that was previously masked by lower social demands

Cevap

An underlying neurodevelopmental disorder that was previously masked by lower social demands
The patient exhibits the core diagnostic criteria for Autism Spectrum Disorder (ASD): pervasive deficits in social communication and interaction, alongside restricted, repetitive patterns of behavior, interests, and activities. She demonstrates an inability to naturally understand nonverbal cues (facial expressions) and the rules of conversation. Furthermore, she exhibits sensory hypersensitivity (pain from fluorescent lights and noise), highly restricted interests (19th-century royalty), and an insistence on sameness (meltdowns with routine changes). In individuals with ASD who have intact language and intellectual abilities—especially females—the disorder may go unrecognized in early childhood. These individuals often learn to 'camouflage' or mask their neurodevelopmental deficits by intellectually analyzing and mimicking normal social behavior. However, as the complexity of social interactions increases during adolescence (e.g., transitioning to high school), the cognitive effort required to maintain this camouflage often leads to extreme exhaustion, anxiety, and functional decline.

Adım Adım Çözüm

1
Analyze the patient's social and interpersonal deficits.
The patient struggles with intuitive social understanding (cannot read facial expressions, must rehearse conversations) rather than just fearing negative judgment.
To differentiate fundamental social communication deficits from anxiety-based avoidance.
2
Identify restricted and repetitive behaviors.
She displays an intense, exclusive interest in royalty, requires rigid routines, and has significant sensory hypersensitivity to lights and noise.
These are the core diagnostic criteria for Autism Spectrum Disorder (ASD).
3
Evaluate the clinical timeline and developmental history.
Normal early milestones with lifelong 'solitary' traits, followed by severe decompensation and 'burnout' upon entering the complex environment of high school.
Higher social demands in adolescence often unmask previously compensated (camouflaged) ASD, a presentation frequently seen in females.

Anahtar Kavram

Autism Spectrum Disorder (ASD) without intellectual impairment can present in adolescence, particularly in females, when complex social demands exceed the patient's capacity to camouflage their underlying social communication deficits.
Tahmini Süre:1m 30s
ÖncekiSayfa 29 / 41Sonraki